Joseph W. LaPlume

All filings by Joseph W. LaPlume on record concern Charles River Laboratories International, Inc., in the capacity of senior executive. In total, 46 filings cover trades dated from 28 May 2021 to 10 August 2026.

On the open market, the record shows 1 purchase worth €3,730 and 15 sales worth €3.2M. Netting one side against the other leaves €3.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 22 share grants and 2 option exercises. Since January 2026: 1 purchase and 1 sale on the market.

Most recently, on 11 August 2026, the filings show a transaction in Charles River Laboratories International, Inc. The latest purchase dates back some time: it was published 228 days ago, on 4 March 2026. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.